Quipt Home Medical Corp. (the “
Company”)
(NASDAQ:QIPT; TSXV:QIPT), a U.S. based home medical equipment
provider, focused on end-to-end respiratory care, is very pleased
to announce it is on a preliminary list dated May 19, 2023 issued
by FTSE Russell to join the Russell 2000
® and
3000
® Indexes at the conclusion of the 2023
Russell indexes annual reconstitution, effective after the U.S.
market opens on June 26, 2023. Updates are provided by the Russell
Microcap Index on May 26, June 2, June 9, June 16 and June 23.
Annual Russell indexes reconstitution captures
the 4,000 largest US stocks as of April 28, 2023, ranking them by
total market capitalization. Membership in the US all-cap Russell
3000® Index, which remains in place for one year, means automatic
inclusion in the large-cap Russell 1000 Index or small-cap Russell
2000 Index as well as the appropriate growth and value style
indexes. FTSE Russell determines membership for its Russell indexes
primarily by objective, market-capitalization rankings, and style
attributes.
“Being included in the Russell
2000® and 3000® Indexes would be
an affirmation of our strategic journey and a testament to the
relentless efforts of our team. We remain committed to delivering
sustained value to our shareholders and are thrilled by the idea of
being included with some of the most forward-thinking companies in
the United States, which we believe would considerably increase our
visibility and access to the worldwide investment community,”
commented Greg Crawford, CEO and Chairman of Quipt. “This inclusion
would truly reflect the substantial growth experienced by our
company and our evolution as a publicly traded company over the
last several years. We are extremely well positioned to continue
executing on our growth strategy, which has yielded robust and
consistent financial performance, and we look forward to providing
our shareholders with updates as we progress on our future
vision."
For more information on the Russell
2000® and 3000® Indexes and the
Russell indexes reconstitution, go to the “Russell Reconstitution”
section on the FTSE Russell website.
About Quipt Home Medical Corp.
The Company provides in-home monitoring and
disease management services including end-to-end respiratory
solutions for patients in the United States healthcare market. It
seeks to continue to expand its offerings to include the management
of several chronic disease states focusing on patients with heart
or pulmonary disease, sleep disorders, reduced mobility, and other
chronic health conditions. The primary business objective of the
Company is to create shareholder value by offering a broader range
of services to patients in need of in-home monitoring and chronic
disease management. The Company’s organic growth strategy is to
increase annual revenue per patient by offering multiple services
to the same patient, consolidating the patient’s services, and
making life easier for the patient.
About FTSE Russell
FTSE Russell is a global index leader that
provides innovative benchmarking, analytics and data solutions for
investors worldwide. FTSE Russell calculates thousands of indexes
that measure and benchmark markets and asset classes in more than
70 countries, covering 98% of the investable market globally. FTSE
Russell index expertise and products are used extensively by
institutional and retail investors globally. For over 30 years,
leading asset owners, asset managers, ETF providers and investment
banks have chosen FTSE Russell indexes to benchmark their
investment performance and create ETFs, structured products and
index-based derivatives. For more information, visit
www.ftserussell.com.
Reader Advisories
While the Company is on the May 19, 2023
preliminary list for inclusion on the Russell
2000® and 3000® Indexes, no
assurance can be given that it will ultimately be on the final
list.Neither the TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of
the TSX Venture Exchange)
accepts responsibility for the adequacy or
accuracy of this release.
Forward-Looking Statements
Certain statements contained in this press
release constitute "forward-looking information" as such term is
defined in applicable Canadian securities legislation. The
words "may", "would", "could", "should", "potential", "will",
"seek", "intend", "plan", "anticipate", "believe", "estimate",
"expect", "outlook", and similar expressions as they relate to
the Company, including: inclusion on the Russell
2000® and 3000® Indexes and the
results of such inclusions; and the Company believing joining the
indexes would significantly bolster its visibility and access to
the global investment community; are intended to identify
forward-looking information. All statements other than statements
of historical fact may be forward-looking information. Such
statements reflect the Company's current views and intentions
with respect to future events, and current information available
to the Company, and are subject to certain risks, uncertainties
and assumptions, including: the Company meeting the inclusion
standards of the Russell 2000® and
3000® Indexes. Many factors could cause the
actual results, performance or achievements that may be expressed
or implied by such forward-looking information to vary from
those described herein should one or more of these risks or
uncertainties materialize. Examples of such risk factors
include, without limitation: risks related to credit, market
(including equity, commodity, foreign exchange and interest
rate), liquidity, operational (including technology and
infrastructure), reputational, insurance, strategic, regulatory,
legal, environmental, and capital adequacy; the general business
and economic conditions in the regions in which the Company
operates; the ability of the Company to execute on key
priorities, including the successful completion of acquisitions,
business retention, and strategic plans and to attract, develop
and retain key executives; difficulty integrating newly acquired
businesses; the ability to implement business strategies and
pursue business opportunities; low profit market segments;
disruptions in or attacks (including cyber-attacks) on the
Company's information technology, internet, network access or
other voice or data communications systems or services; the
evolution of various types of fraud or other criminal behavior
to which the Company is exposed; the failure of third parties to
comply with their obligations to the Company or its affiliates;
the impact of new and changes to, or application of, current laws
and regulations; decline of reimbursement rates; dependence on
few payors; possible new drug discoveries; a novel business
model; dependence on key suppliers; granting of permits and
licenses in a highly regulated business; the overall difficult
litigation environment, including in the U.S.; increased
competition; changes in foreign currency rates; increased
funding costs and market volatility due to market illiquidity
and competition for funding; the availability of funds and
resources to pursue operations; critical accounting estimates and
changes to accounting standards, policies, and methods used by
the Company; the occurrence of natural and unnatural catastrophic
events and claims resulting from such events; and risks related
to COVID-19 including various recommendations, orders and
measures of governmental authorities to try to limit the
pandemic, including travel restrictions, border closures,
non-essential business closures, quarantines, self-isolations,
shelters-in-place and social distancing, disruptions to markets,
economic activity, financing, supply chains and sales channels,
and a deterioration of general economic conditions including a
possible national or global recession; as well as those risk
factors discussed or referred to in the Company’s disclosure
documents filed with United States Securities and Exchange
Commission and available at www.sec.gov, and with the
securities regulatory authorities in certain provinces of Canada
and available at www.sedar.com. Should any factor affect the
Company in an unexpected manner, or should assumptions
underlying the forward-looking information prove incorrect, the
actual results or events may differ materially from the results
or events predicted. Any such forward-looking information is
expressly qualified in its entirety by this cautionary
statement. Moreover, the Company does not assume responsibility
for the accuracy or completeness of such forward-looking
information. The forward-looking information included in this
press release is made as of the date of this press release and
the Company undertakes no obligation to publicly update or revise
any forward-looking information, other than as required by
applicable law.
For further information please visit our website
at www.Quipthomemedical.com, or contact:
Cole StevensVP of Corporate DevelopmentQuipt
Home Medical Corp.859-300-6455cole.stevens@myquipt.com
Gregory CrawfordChief Executive OfficerQuipt
Home Medical Corp.859-300-6455investorinfo@myquipt.com
Quipt Home Medical (TSXV:QIPT)
過去 株価チャート
から 11 2024 まで 12 2024
Quipt Home Medical (TSXV:QIPT)
過去 株価チャート
から 12 2023 まで 12 2024
